Anticoagulant

Anticoagulant has been studied in 5 papers since 2022: 4 observational studies in people, 1 review; 1 in the past year. The newest paper, Jan 27, 2026: “Artificial intelligence in atrial fibrillation - Timely diagnosis, risk assessment and personalized management”.

5 papers study it2 findingsUpdated Jan 27, 2026

At a glance

The findings reach people, from one lab or study. 2 independent labs in 2 countries; 7 trials, none about aging, 3 with no results posted.

“anticoagulant use and blood transfusion were identified as risk factors for lower SF-36 scores”

None of its findings points the other way.

Studies link anticoagulant with 2 measures: quality of life and mortality.

Quality of life

downin humans1

1 study

Anticoagulant is associated with quality of life in humans (intertrochanteric fracture).
“anticoagulant use and blood transfusion were identified as risk factors for lower SF-36 scores”
Humansintertrochanteric fracturen = 310
Factors associated with postoperative quality of life in patients with intertrochanteric fracture
Annals of medicine and surgery (2012)Dec 11, 2023

Mortality

upin humans1

1 study

Anticoagulant is associated with mortality in humans (geriatric orthopaedic trauma patients admitted to ICU).
“The relative risk for mortality within the first month was significantly associated with increased age, ISS, high-energy trauma, length of ICU stay, MODS, psychiatric disease, and anticoagulant use.”
Humansgeriatric orthopaedic trauma patients admitted to ICUfirst monthn = 174
Factors Influencing Geriatric Orthopaedic Trauma Mortality
InjuryJan 5, 2022

0 of 7 about aging

Yes: 4 observational studies in people have been published, and 7 trials are registered.

All 10

NCT03073850TerminatedAtrial fibrillation
Majority of enrolled patients have withdrawn.
NCT00443573SuspendedAdenocarcinoma
Company suspended development of product.